Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATHAR: Rivaroxaban for Mechanical Aortic Valve
NCT02128841Phase 2Terminated
- Sponsor
- Insel Gruppe
- Start
- Sep 2012
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in thromboembolism, sponsored by Insel Gruppe. Started Sep 2012; status: terminated.
02
Drugs
rivaroxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02128841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128841.